GC Biopharma Corp. (KRX:006280)

South Korea · Delayed Price · Currency is KRW

122,100

-600 (-0.49%)

Sep 18, 2026, 9:35 AM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Manufacturing and Sales of Pharmaceuticals, Etc.	1.98T	1.58T	1.44T	1.48T	-
Diagnosis and Analysis of Samples, Etc.	181.90B	200.12B	213.76B	262.18B	-
Other	14.15B	16.06B	18.50B	22.10B	-
Consolidation Adjustment	-187.31B	-117.27B	-46.49B	-57.45B	-
Energy Storage Device Manufacturing and Sales	-	-	-	-	1.54T
Total	1.99T	1.68T	1.63T	1.71T	1.54T

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	1.55T	1.42T	1.40T	1.46T	9.50B
Overseas	626.44B	380.65B	272.87B	306.71B	39.46B
Consolidation	-187.31B	-117.27B	-46.49B	-57.45B	-
Total	1.99T	1.68T	1.63T	1.71T	48.96B